Ratings by Wells Fargo (Lawrence Biegelsen)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/23/2021 Eargo Inc. EAR Downgrade Equal Weight
(Overweight)
22.06
(6.47)
-70.67% Details
9/15/2021 Boston Scientific BSX Maintain Overweight
(N/A)
 
 
  Details
8/6/2021 Becton Dickinson BDX Maintain Equal Weight
(N/A)
 
 
  Details
8/5/2021 Nevro Corp NVRO Downgrade Equal Weight
(Overweight)
151.19
(123.31)
-18.44% Details
8/2/2021 Boston Scientific BSX Maintain Overweight
(N/A)
 
 
  Details
7/30/2021 Edwards Lifesciences EW Maintain Equal Weight
(N/A)
 
 
  Details
7/30/2021 DexCom DXCM Maintain Equal Weight
(N/A)
 
 
  Details
5/28/2021 DexCom DXCM Upgrade Equal Weight
(Underweight)
354.69
(573.18)
61.6% Details
4/30/2021 DexCom DXCM Maintain Underweight
(N/A)
 
 
  Details
4/21/2021 Edwards Lifesciences EW Maintain Equal Weight
(N/A)
 
 
  Details
3/10/2021 Inari Medical Inc. NARI Maintain Overweight
(N/A)
 
 
  Details
1/20/2021 Inari Medical Inc. NARI Maintain Overweight
(N/A)
 
 
  Details
12/15/2020 Inari Medical Inc. NARI Upgrade Overweight
(Equal Weight)
66.85
(79.08)
18.29% Details
12/15/2020 Tandem Diabetes Care TNDM Downgrade Underweight
(Equal Weight)
91.00
(124.87)
37.22% Details
12/15/2020 Becton Dickinson BDX Downgrade Equal Weight
(Overweight)
242.69
(255.93)
5.46% Details
11/18/2020 Edwards Lifesciences EW Maintain Equal Weight
(N/A)
 
 
  Details
10/2/2020 DexCom DXCM Downgrade Underweight
(Equal Weight)
412.23
(573.18)
39.04% Details
7/24/2020 Edwards Lifesciences EW Maintain Equal Weight
(N/A)
 
 
  Details
4/28/2020 Edwards Lifesciences EW Downgrade Equal Weight
(Overweight)
223.48
(121.15)
-45.79% Details
6/26/2019 Baxter International BAX Maintain Overweight
(N/A)
 
 
  Details